纤维化
肾
癌症研究
发病机制
下调和上调
缺氧诱导因子
生物
医学
内分泌学
内科学
生物化学
基因
作者
Disheng Liu,Haonan Sun,Kan Li,Zhiyu Zhao,Zhenzhen Liu,Guangru Zhang,Yan Gao,Jinduo Zhang,Degui Wang,Yufang Leng
标识
DOI:10.1016/j.bbrc.2022.06.008
摘要
Hypoxia-inducible factor 1-α (HIF-1α) mediates the occurrence and development of renal diseases and fibrosis. In the process, dysregulated cellular metabolism was suggested to be involved in several pathological processes. Here, we found that HIF-1α expression was increased in the early stage of renal fibrosis, and significant metabolic remodeling was triggered. Epigenetic events that drive diseases were characterized previously. Our study showed that ten-eleven translocation-2 (TET2) was upregulated in both renal fibrosis models and metabolite-treated samples. Furthermore, we found that the promoter of α-SMA was hypomethylated at CpG sites, which promoted the expression of α-SMA and the occurrence of renal fibrosis. HIF-1α inhibition alleviated renal fibrosis development by improving metabolic remodeling and TET2 activation. Our studies provide novel insight into HIF-1α-mediated metabolic remodeling in the pathogenesis of renal fibrosis and propose a concept that targets this pathway to treat fibrotic disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI